Incretin-based therapies, including agonists of the [glucagon-like peptide 1] and [glucose-dependent insulinotropic polypeptide] receptors, have been shown to reduce liver fat and improve steatohepatitis-related biomarkers in patients with steatotic liver disease, Arun J
Notably, a study elucidated that the ferroptosis inducer sulfasalazine significantly impedes the management of rheumatic skeletal disorders [32]
Peptide therapy is considered to be a very safe form of treatment, with minimal side effects
Conings S, Tseke F, Van den Broeck A, et al
PMID: 79 AbdullaSAevermannBAssisPBadajozSBellSMProgram CS-CBet al
Serotonin helps regulate mood, appetite, and sleep, amongst others